ANTISTREPTOLYSIN - ANVISA Registration 80022230183

Access comprehensive regulatory information for ANTISTREPTOLYSIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80022230183 and manufactured by GOLD ANALISA DIAGNOSTICA LTDA. The registration is held by GOLD ANALISA DIAGNOSTICA LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including BIOSYSTEMS S.A., KOVALENT DO BRASIL LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80022230183
Registration Details
ANVISA Registration Number: 80022230183
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

AEO Látex
Risk Class II

Registration Details

80022230183

25351094564201443

03142794000116

Company Information

Brazil
PT: BRASIL

Dates and Status

Apr 14, 2014

VIGENTE

09/18/2025 19:00:01